Bilayer/cytoskeleton interactions in lipid-symmetric erythrocytes assessed by a photoactivable phospholipid analogue.
Two mechanisms have been proposed for maintenance of transbilayer phospholipid asymmetry in the erythrocyte plasma membrane, one involving specific interactions between the aminophospholipids of the inner leaflet of the bilayer and the cytoskeleton, particularly spectrin, and the other involving the aminophospholipid translocase. If the former mechanism is correct, then erythrocytes which have lost their asymmetric distribution of phospholipids should display altered bilayer/cytoskeleton interactions. To test this possibility, normal erythrocytes, erythrocytes from patients with chronic myelogenous leukemia or sickle disease, and lipid-symmetric and -asymmetric erythrocyte ghosts were labeled with the radioactive photoactivable analogue of phosphatidylethanolamine, 2-(2-azido-4-nitrobenzoyl)-1-acyl-sn-glycero-3-phospho[14C]ethanolamine ([14C]AzPE), previously shown to label cytoskeletal proteins from the bilayer. The labeling pattern of cytoskeletal proteins in pathologic erythrocytes and lipid-asymmetric erythrocyte ghosts was indistinguishable from normal erythrocytes, indicating that the probe detects no differences in bilayer/cytoskeleton interactions in these cells. In contrast, in lipid-symmetric erythrocyte ghosts, labeling of bands 4.1 and 4.2 and actin, and to a lesser extent ankyrin, by [14C]AzPE was considerably reduced. Significantly, however, labeling of spectrin was unaltered in the lipid-symmetric ghosts, suggesting that its relationship with the bilayer is normal in these lipid-symmetric cells. These results do not support a model in which spectrin is involved in the maintenance of an asymmetric distribution of phospholipids in erythrocytes.
Pradhan
D
D
Department of Molecular and Cell Biology, Pennsylvania State University, University Park 16802.
Williamson
P
P
Schlegel
R A
RA
D000345:Affinity Labels / Q000378:metabolism; D002352:Carrier Proteins / Q000097:blood; D003598:Cytoskeletal Proteins / Q000097:blood* / Q000302:isolation & purification; D003599:Cytoskeleton / Q000378:metabolism*; D004910:Erythrocyte Membrane / Q000378:metabolism*; D004912:Erythrocytes / Q000378:metabolism*; D006801:Humans; D008051:Lipid Bilayers; D008565:Membrane Proteins / Q000097:blood; D010714:Phosphatidylethanolamines / Q000097:blood*; D049294:Phospholipid Transfer Proteins; D011485:Protein Binding; D013049:Spectrin / Q000378:metabolism
D000345:Affinity Labels; D002352:Carrier Proteins; D003598:Cytoskeletal Proteins; D008051:Lipid Bilayers; D008565:Membrane Proteins; D010714:Phosphatidylethanolamines; D049294:Phospholipid Transfer Proteins; C061749:2-(2-azido-4-nitrobenzoyl)-1-myristoylglycero-3-phosphoethanolamine; D013049:Spectrin